NEW YORK, July 15, 2013 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Celsion Corp. ("Celsion" or the "Company") (NasdaqCM: CLSN -News). The investigation focuses on whether the Company and its executives violated federal securities laws.
On June 11, 2013, shares of Celsion declined after an article was published by market commentator Alpha Exposure asserting that the Company's statistical findings from the Phase III ThermoDox HEAT study announced on April 23, 2013 should be viewed with "extreme skepticism" and that "having reviewed the Phase III results and subgroup analysis, all the doctors we spoke with unanimously believed that Celsion has no chance of regulatory approval."
If you are aware of any facts relating to this investigation, or purchased shares of Celsion you can assist this investigation by contacting either Peretz Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman 212-697-6484
SOURCE Bronstein, Gewirtz & Grossman, LLC